Bio prospects for CEO
Tuesday, 23 September, 2008
Peter May has been appointed as the new CEO of Brisbane agribiotech BioProspect, taking over from Warwick Dowse, who has returned to New Zealand.
May has previously worked with CFL, Incitec and Crop Care Australasia, and has run his own consultancy since 2001, working with the likes of Syngenta. He will officially take up the job on November 3.
BioProspect focuses on the discovery, research and development of commercial products from Australian botanical sources.
It is currently developing two main products: a natural termite compound called Termilone and a range of natural plant extracts for application in the animal nutrition, health and agricultural markets called Bioeffectives.
SEQ koala population carries immunity to retrovirus
Koalas from a population north of the Brisbane River appear to have evolved a unique genomic...
RSV immunisation program for babies slashes hospital stays
An Australian-first study has demonstrated the effectiveness of immunisation against respiratory...
A targeted treatment option for psoriasis
New research from MedUni Vienna paves the way for the development of a therapy that not only...
